首页> 美国卫生研究院文献>The British Journal of Ophthalmology >A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies
【2h】

A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies

机译:一种假设表明光是青光眼和线粒体视神经病变的危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The authors propose that light entering the eye interacts with retinal ganglion cell (RGC) axon mitochondria to generate reactive oxygen intermediates (ROI) and that when these neurons are in an energetically low state, their capacity to remove these damaging molecules is exceeded and their survival is compromised. They suggest that in the initial stages of glaucoma, RGCs exist at a low energy level because of a reduced blood flow at the optic nerve head and that in the mitochondrial optic neuropathies (MONs), this results from a primary, genetic defect in aerobic metabolism. In these states RGCs function at a reduced energy level and incident light on the retina becomes a risk factor. Preliminary laboratory studies support this proposition. Firstly, the authors have shown that light is detrimental to isolated mitochondria in an intensity dependent manner. Secondly, light triggers apoptosis of cultured, transformed RGCs and this effect is exacerbated when the cells are nutritionally deprived. Detailed studies are under way to strengthen the proposed theory. On the basis of this proposal, the authors suggest that patients with optic neuropathies such as glaucoma or at risk of developing a MON may benefit from the use of spectral filters and reducing the intensity of light entering the eye.
机译:作者提出,进入眼睛的光与视网膜神经节细胞(RGC)轴突线粒体相互作用以生成活性氧中间体(ROI),并且当这些神经元处于能量低状态时,其清除这些有害分子的能力就会超过其存活率被妥协了。他们认为,在青光眼的初始阶段,RGC处于较低的能量水平,这是因为视神经头处的血流量减少以及线粒体视神经病变(MONs)中的原因,这是有氧代谢的主要遗传缺陷导致的。在这些状态下,RGC在降低的能量水平下运行,入射在视网膜上的光成为危险因素。初步的实验室研究支持这一主张。首先,作者表明光以强度依赖的方式有害于分离的线粒体。其次,光触发培养的转化的RGC的凋亡,当细胞营养缺乏时,这种作用会加剧。为了加强所提出的理论,正在进行详细的研究。根据该建议,作者建议患有视神经病变(例如青光眼)或有发生MON的风险的患者可能会受益于使用光谱滤光片并降低进入眼睛的光强度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号